Column Group

Latest statistics and disclosures from Column Group's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are Surrozen, ORIC, RVMD, and represent 100.00% of Column Group's stock portfolio.
  • Added to shares of these 1 stock: Surrozen.
  • Reduced shares in these 2 stocks: TNYA (-$6.7M), Rapt Therapeutics (-$5.3M).
  • Sold out of its positions in Rapt Therapeutics, TNYA.
  • Column Group was a net seller of stock by $-10M.
  • Column Group has $101M in assets under management (AUM), dropping by 21.64%.
  • Central Index Key (CIK): 0001833486

Tip: Access up to 7 years of quarterly data

Positions held by Column Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Column Group

Column Group holds 3 positions in its portfolio as reported in the March 2026 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Surrozen 55.4 $56M +3% 1.9M 29.13
 View chart
Oric Pharmaceuticals (ORIC) 44.5 $45M 3.5M 12.67
 View chart
Revolution Medicines (RVMD) 0.0 $4.5k 46.00 97.26
 View chart

Past Filings by Column Group

SEC 13F filings are viewable for Column Group going back to 2020

View all past filings